SAIVI™715 injectable contrast agents are polymeric microspheres that have been labeled with a fluorescent dye. These contrast agents have been observed to circulate throughout the blood and to accumulate in tissues that exhibit damaged, excessive, or otherwise abnormal blood vessel development as part of the disease process. SAIVI™715 injectable contrast agents are optimized for emission intensity and tested by in vivo imaging after injection in disease models established in mice.